Liu Feihong

Managing Director

15 past transactions

Yuefang Technology

Series A in 2023
Yuefang Technology is a chip design company initiated and established by Galanz Group.

Beilai Bio

Series B in 2022
Beilai Bio is a clinical-stage biopharmaceutical company focused on the development of stem cell therapeutics for various diseases, particularly those with high unmet medical needs. Its established technology platforms allow them to produce clinical-grade "off-the-shelf" Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC) from an unlimited supply of cord tissues that are traditionally regarded as medical waste.

Zhide New Energy

Series B in 2022
Zhide New Energy is a developer of approaches to synthetize new silicon anode materials. They focuses on silicon technology that can be applied to produce new materials. They also produce battery with high energy density and low cost. They manufactures battery for 3C and EV. They provide batteries for fields, such as electric vehicles, consumer electronics, house power storage, and wearable devices.

Sunwoda Electronic

Post in 2022
Sunwoda Electronic is a high-tech enterprise with the R&D, design, production, and sale of lithium-ion battery cells and modules as its main business. They are committed to providing eco-friendly and efficient energy-integrated solutions.

CYGNUSEMI

Series A in 2022
Cygnus Semi is a semiconductor chip technology company that focuses on 5G IoT applications.
Core Long March Technology is a high-tech design company specializing in the development of new power semiconductor devices. Its core business includes: coolmos, SiC and other chip products and technology development. The technical team is based on the technical experts of the Chinese Academy of Sciences and the introduction of outstanding overseas technical elites. The core members of the team have more than 6 years of product development experience, and realize the whole chain from chip design, manufacturing process, packaging and testing, reliability and application. The company has a professional marketing and operation management team. It is very familiar with the technology, industry and market in this direction and has good operational capabilities. The technical and management teams have gone through the process from technology development to sample to product to mass production to complete marketization. .

MingMed

Series A in 2021
MingMed is a Chinese company with global competitiveness in independent drug research and development. The company's main product pipeline includes, among other things, ophthalmic drugs, recombinant protein botulinum toxin, tumor immune drugs, and pet immune drugs, as well as a number of potential First-in-Class innovative drugs that have reached the clinical stage.

WeRide

Series B in 2021
WeRide is a leading, commercial-stage global company that develops Level 4 autonomous driving technologies. WeRide aims to develop safe and reliable driverless solutions to make mobility and transportation safer, more affordable and accessible. WeRide is conducting autonomous driving R&D, tests and operations in over 25 cities around the world. As the pioneer leader in autonomous technologies and services, WeRide has stepped up to the commercial stage in operations. WeRide offers an all-rounded product mix of Robotaxi, Robobus, Robovan, Robosweeper and ADAS, providing smart services in online ride-hailing, on-demand transport, urban logistics, sanitation services and acting as a solution provider. Established in 2017, WeRide is headquartered in Guangzhou, China, and has expanded its R&D and operation centers to Beijing, Shanghai, Shenzhen, Zhengzhou, Nanjing, Wuhan, and Anqing, as well as San Francisco in the US. WeRide has formed strategic partnerships with leading global OEMs and Tier 1 supplier including Renault-Nissan-Mitsubishi Alliance, Yutong Group, GAC Group, Bosch, etc.

MabPlex

Series B in 2020
MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. They offer partners contract services from DNA to finished drug product. They offer comprehensive biologics development and manufacturing solutions for customers globally.

Kingsware

Series A in 2020
Kingsware specializes in developing a robotic process automation system. It is committed to building an enterprise-level safe robot management platform. Its product follows the design concept of safe, easy-to-use, powerful, stable, and efficient, and the system can be deployed and controlled in a large-scale, highly integrated enterprise complex environment.

Mabwell Biotech

Series A in 2020
Mabwell Biotech is a Chinese innovative biopharmaceutical company based in Shanghai Zhangjiang Hi-Tech Park. Since its establishment in 2017, it has absorbed and newly established nine biopharmaceutical R&D and production enterprises. At present, the company focuses on the development and manufacturing of macromolecular drugs such as therapeutic monoclonal antibodies and long-acting recombinant proteins. There are more than thirty varieties of drugs at different stages of development covering tumor, autoimmunity, anti-infection and ophthalmic diseases. Among them, six of them have entered the clinical stage, and three of them are in Phase III clinical trials.
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Insta360

Series C in 2019
Insta360 is a professional intelligent technology company that offers cameras that empowers people to freely share experiences. The company makes cameras that allow you to share everything, everywhere. From the 8K Insta360 Pro for professional creators, to the matchlessly versatile Insta360 ONE, Insta360's cameras allows to capture big moments in immersive detail. Founded in 2014, Insta360 is the world leader in 360-degree cameras. Based in Shenzhen and immersed in the city’s incomparable hardware ecosystem, Insta360 prides itself on creating groundbreaking products that push the envelope of both performance and accessibility. With an Insta360 camera, users can take 360-degree photos and videos in high definition, and live-stream their experiences directly onto Facebook, Twitter, YouTube and other social platforms. When viewed in a VR headset, Insta360 experiences can transport people into places and moments they’ve never before imagined.

Das Security

Venture Round in 2017
Das Security is a provider of information security technology services, offering many comprehensive solutions like application security, database security, website security monitoring, and a digital security management platform. The company maintains its corporate purpose of creating a safe and credible digital world, supports, customer success, responsibility first, open innovation, and people-oriented, common growth as the company's values, and positions itself as the security cornerstone of digitalization. It is committed to leading the global digital security industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.